Evidence map›Paper›PMID 40430440›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Exploring Therapeutic Potential of Bi-Qi Capsules in Treatment of Gout by Discovering Crucial Drug Targets.

Jing Xie, Yu Zhang, Rong Ren, Ruizhen Bu, Liying Chen, Juezhuo Hou, Dandan Shang, Yadong Liu, Dan Wang, Tao Wang and 1 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing XieState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Yu ZhangTianjin Pharmaceutical Da Ren Tang Group Co., Ltd., 17 Baidi Road, Nankai District, Tianjin 300193, China.
Rong RenTianjin Pharmaceutical Da Ren Tang Group Co., Ltd., 17 Baidi Road, Nankai District, Tianjin 300193, China.
Ruizhen BuTianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., 20 Daming Road, Xiqing District, Tianjin 300112, China.
Liying ChenTianjin Key Laboratory of Quality Control in Chinese Medicine, 21 10th Street, Binhai New Area, Tianjin 300457, China.
Juezhuo HouTianjin Pharmaceutical Da Ren Tang Group Co., Ltd., 17 Baidi Road, Nankai District, Tianjin 300193, China.
Dandan ShangTianjin Pharmaceutical Da Ren Tang Group Co., Ltd., 17 Baidi Road, Nankai District, Tianjin 300193, China.
Yadong LiuTianjin Pharmaceutical Da Ren Tang Group Co., Ltd., 17 Baidi Road, Nankai District, Tianjin 300193, China.
Dan WangState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Tao WangState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Hong ZhouTianjin Pharmaceutical Da Ren Tang Group Co., Ltd., 17 Baidi Road, Nankai District, Tianjin 300193, China.

Funding

Foundation of State Key Laboratory of Bioactive Substance and Function of Natural Medicines GTZK202208Tianjin Municipal Health Commission Project 2024009
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bi-Qi capsulegoutMendelian randomizationnetwork pharmacologytraditional Chinese medicine

Identifiers

PMID40430440
PMCPMC12114690

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.